The proposed bill, known as the Patient Protection Act, aims to establish specific conditions for prescribing dangerous drugs that are associated with severe adverse effects. It introduces a new section, 3715.39, to the Revised Code, which defines key terms such as "dangerous drug," "prescriber," and "severe adverse effect." The bill outlines that a "severe adverse effect" includes serious health issues such as death, hospitalization due to infection or hemorrhaging, organ failure, and sepsis.

Before a prescriber can issue a prescription for a dangerous drug that has a severe adverse effect rate exceeding five percent among users, they must conduct an in-person examination, inform the patient about the risks, and schedule a follow-up appointment. The bill designates the director of health to determine which drugs meet this criterion, requiring consultation with relevant state officials and the use of data from insurance claims and the FDA. Additionally, the director is tasked with maintaining and publicly updating a list of such dangerous drugs on the department of health's website.